Clinical Liver Disease
Immunosuppression: Conventions and Controversies - Neil Mehta and Ryutaro Hirose – Article Reading
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:12
- Mas informaciones
Informações:
Sinopsis
Liver transplant recipients generally need lifelong immunosuppression - approximately 7 to 17 per cent of patients experience an episode of acute cellular rejection with 3 to 12 months of LT, respectively.